Jiangxi Fushine Pharmaceutical Co., Ltd. (300497.SZ) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 20Aug 25Aug 28Sep 2Sep 7Sep 10Sep 15Sep 18

Key dataSep 18, 2026

OpenCNY 21.86

From 52W high−27.08%

Volume56.52M

Market capCNY 9.17B

P/E (TTM)−166.6x

P/S (TTM)8.8x

Div yield0.23%

Key dataSep 18, 2026

Open

CNY 21.86

From 52W high

−27.08%

Volume

56.52M

Market cap

CNY 9.17B

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

101.8x

P/E (TTM)

−166.6x

RSI (14)

68.8

MomentumView details →

1D Return

−1.45%

YTD Return

+41.50%

ValuationView details →

P/E (Fwd)

—

P/E (TTM)

−166.6x

EV/EBITDA

101.8x

EV/Sales

9.6x

P/S (TTM)

8.8x

P/B (TTM)

3.9x

ProfitabilityView details →

Gross Margin

22.91%

Net Margin

0.30%

EBITDA Margin

9.47%

ROE (TTM)

0.17%

ROA (TTM)

0.09%

Asset Turnover

0.29x

GrowthView details →

Revenue YoY

+22.21%

EPS YoY

+101.58%

FCF YoY

−39.74%

Revenue CAGR 3Y

−10.40%

EPS CAGR 3Y

+80.39%

EBITDA YoY

—

MomentumView details →

1D Return

−1.45%

YTD Return

+41.50%

1Y Return

+96.69%

RSI (14)

68.8

vs 50D SMA

+18.10%

vs 200D SMA

+24.30%

Capital & dividendView details →

Debt/Equity

0.69x

Current Ratio

1.22x

Quick Ratio

0.92x

Div Yield

0.23%

Div Rate

CNY 0.05

Div Growth 1Y

−75.00%

EarningsView details →

EPS (Actual)

—

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

CNY 0.00

Avg Surprise (4Q)

—

Rev Surprise

—

Financials snapshotView financials →

Revenue (TTM)

1.31B

Net Income (TTM)

3.93M

Op. CF (TTM)

42.70M

Latest newsMore news →

Fuxiang Co., Ltd. announced preliminary guidance for the first three quarters of 2026, expecting net profit attributable to shareholders of RMB 350-430 million, turning profitable year-on-year from a loss of RMB 62.7515 million, driven by higher volumes and prices of new-energy lithium battery electrolyte additive products.3d ago

Fuxiang Co., Ltd. reported H1 2026 revenue of 888 million yuan, up 72.59% year-on-year, and net profit of 177 million yuan, turning from loss to profit, driven by price increases and capacity expansion in electrolyte additives.38d ago

Similar companies

新华制药000756.SZ 兴瑞科技002937.SZ 探路者300005.SZ 伊之密300415.SZ ST天际002759.SZ 新开源300109.SZ Find similar companies →

Latest newsMore news →

Fuxiang Co., Ltd. announced preliminary guidance for the first three quarters of 2026, expecting net profit attributable to shareholders of RMB 350-430 million, turning profitable year-on-year from a loss of RMB 62.7515 million, driven by higher volumes and prices of new-energy lithium battery electrolyte additive products.3d ago Fuxiang Co., Ltd. reported H1 2026 revenue of 888 million yuan, up 72.59% year-on-year, and net profit of 177 million yuan, turning from loss to profit, driven by price increases and capacity expansion in electrolyte additives.38d ago